Key legal info on regulatory reforms in Estonia. Prepared in association with TGS Baltic, a leading law firm in Estonia, this is an extract from The Pharma Legal Handbook: Baltics, available to purchase here for GBP 99.
1. Are there proposals for reform or significant change to the healthcare system?
Pharmacy reform (ownership restrictions), that concerned mainly chain pharmacies, took full effect on April 1 2020. Most chain pharmacies complied to new requirements by due date and operate now under franchise scheme. The aim of the reform was to separate wholesale and retail sale of medicines and to establish a system where more than 50 per cent of the shares of the pharmacy and the dominant influence must belong to a pharmacist who works as the manager in at least one general pharmacy operating on the basis of an activity license issued to the pharmacy.
On 10 July 2019 a draft law amending the current MPA was published by the Ministry of Social Affairs of Estonia, which concerns, inter alia: wholesale activities of manufacturers, import rights of hospital pharmacies, import and export approvals and notifications, etc.
Estonia is considering similar “no-fault system” mechanism for compensation of damages caused to patients in connection with healthcare services as is established in Finland and in some other countries. The aim of the “no-fault system” is to simplify compensation procedures (currently compensation can be claimed through courts) and to encourage physicians to collaborate with the system in detecting what caused the injuries. Compensation is based on proof of “causal” connection between treatment and injury and proof of negligence is not required.
2. When are they likely to come into force?
Change of liability system of healthcare providers is not likely to come into force in the near future.